Frontage Holdings Corp
HKEX:1521

Watchlist Manager
Frontage Holdings Corp Logo
Frontage Holdings Corp
HKEX:1521
Watchlist
Price: 1.67 HKD 0.6% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
Frontage Holdings Corp?
Write Note

Frontage Holdings Corp
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Frontage Holdings Corp
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
Frontage Holdings Corp
HKEX:1521
Cash Taxes Paid
$12m
CAGR 3-Years
51%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Cash Taxes Paid
$1.6B
CAGR 3-Years
0%
CAGR 5-Years
19%
CAGR 10-Years
11%
Mettler-Toledo International Inc
NYSE:MTD
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Cash Taxes Paid
$314m
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
7%
IQVIA Holdings Inc
NYSE:IQV
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Frontage Holdings Corp
Glance View

Market Cap
3.4B HKD
Industry
Life Sciences Tools & Services

Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.

Intrinsic Value
2.65 HKD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Frontage Holdings Corp's Cash Taxes Paid?
Cash Taxes Paid
12m USD

Based on the financial report for Dec 31, 2023, Frontage Holdings Corp's Cash Taxes Paid amounts to 12m USD.

What is Frontage Holdings Corp's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 5Y
33%

Over the last year, the Cash Taxes Paid growth was 3%. The average annual Cash Taxes Paid growth rates for Frontage Holdings Corp have been 51% over the past three years , 33% over the past five years .

Back to Top